Our Entrepreneur Partners are core to our investment strategy, providing deep domain expertise, capabilities across the entire drug development process and experience navigating the complex regulatory landscape. Our entrepreneurs and investment professionals bring unique expertise to inform every investment decision – private or public, across all phases of development.

MPM BioImpact combines the 30+ year track record of the MPM CAPITAL^® services and offerings in biotech venture capital with BioImpact’s dedication to impact and 10+ years of experience in public investing. Together, we manage over $3 billion AUM across early-stage venture funds, private/public impact funds and a public equities fund.

The BIOIMPACT FUND™ investment approach pioneered by MPM BioImpact features private and public equity funds that invest in companies which aim to transform the lives and outcomes of patients suffering from disease. We are proud to be committed to the Global Standards for managing these impact investments.